TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer.
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024
Project: IC-3i-PhD
Updated at: 28-04-2024